Combined results from two large real-world trials of a high-dose influenza vaccine have found not only does the higher dose provide superior protection against influenza than the standard regimen, it ...

Based on completion of patient randomization, Xenon anticipates topline results from the Phase 2b X-TOLE clinical trial in late September to mid-October 2021.